News and jobs

  • Getting involved in Cochrane’s work means becoming part of a global community. Connect with Cochrane Groups across the world through the Cochrane International Mobility programme!The Cochrane International Mobility programme builds on previous successful student exchanges involving Cochrane Centres around the world. A broader initiative involving...
    16 September 2019
  • Evidence Synthesis - What is it and why do we need it?
    We encounter Evidence Syntheses on an almost day-to-day basis, but do we know what it is and why we need it?Cochrane Ireland and Evidence Synthesis Ireland aims to build knowledge, awareness, and capacity in the methods used to gather and build evidence (known as evidence synthesis) and using it effectively to inform health and healthcare...
    13 September 2019
  • Podcast: Effects of starting antiretroviral therapy within one week of diagnosis on people living with HIV
    Among the dozens of Cochrane Reviews of various treatments for people with HIV or AIDS, are some that look more at how the treatments should be used, rather than the treatments themselves. One of these examines the timing of the start of treatment, and it was published in June 2019. Lead author, Alberto Mateo from the Liverpool School of Tropical...
    13 September 2019
  • Angela Aldin, Research Associate, Cochrane Haematological Malignancies, University Hospital of Cologne, Germany
    Hodgkin lymphoma (HL) is one of the most common haematological malignancies in young adults and, with cure rates of 90%, has become curable for the majority of individuals. Positron emission tomography (PET) is an imaging tool used to monitor a tumour’s metabolic activity, stage and progression. Interim PET during chemotherapy has been posited as...
    11 September 2019
  • Colloquium Scientific Program at a glance
    Cochrane Chile is thrilled to present highlights of this year’s Scientific Program! Cochrane’s annual flagship event brings together hundreds of clinicians, health professionals, policy makers, researchers, patients, consumers and others to discuss and learn about the wide usage of Cochrane evidence in health decision-making at all levels. This...
    11 September 2019
  • The Global Evidence Summit 2021 will be held in October at O2 Universum, the brand new Multifunctional Cultural and Congress Centre in beautiful historic Prague
     Cochrane, JBI, Campbell Collaboration and Guidelines International Network are excited to announce the host of the Global Evidence Summit (GES) 2021 is the Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (CEBHCKT). The Cochrane geographic Centre is a leading national umbrella institution for evidence-based healthcare...
    11 September 2019
  • Treating school children with drugs to kill soil - transmitted worms
    In 2015 Cochrane published a review on this topic, which has now been updated to include six new trials, additional data from included trials, and addresses comments and criticisms.

    Global Advocacy organisations claim routine deworming of all school children at regular intervals with deworming drugs in areas where helminth infection is...
    11 September 2019
  • Cochrane Back and Neck Reviews abracts receive high praise in recent study
    A recent study comparing low back pain systematic review abstracts to their full text was published in the Journal of Orthopaedic & Sports Physical Therapy. Looking at 66 systematic reviews researchers found that 80% of abstracts presented spin and inconsistencies when compared to their full text. Nine of the systematic reviews investigated...
    10 September 2019
  • #SantiagoColloquium - Let's get social!
    We are looking for content creator volunteers who would like to help share the work of Cochrane and extend our annual scientific conference materials and discussion beyond attendees to their social media followers. Cochrane Chile is hosting Cochrane’s Colloquium in Santiago, October 22-25, 2019. Cochrane’s Colloquium is an annual, global health...
    9 September 2019
  • Polycystic Ovary Syndrome Awareness Month
    September is  Polycystic Ovary Syndrome Awareness Month and is an excellent time to focus on the latest Cochrane evidence.Polycystic ovary syndrome (PCOS) is a very common condition affecting 8% to 13% of women. Being overweight worsens all clinical features of PCOS. These clinical features include reproductive issues such as reduced frequency of...
    6 September 2019

Pages

Subscribe to News and jobs